The Prevention and Treatment of the Non-communicable Diseases (NCDs) in Covid-19

Author:

Li Nuoyan

Abstract

Communicable diseases and non-communicable diseases (NCDs) are the two major diseases that affect human health. The former has a wide range of influence and involves a large number of people, while the latter has a long onset time and is difficult to recover once the disease develops. Since 2019, covid-19 has become a global pandemic, killing and infecting millions of people. For patients with NCDs, no matter when vaccinating or taking drugs, there are more things to pay attention to in the prevention and treatment during the covid-19 pandemic. According to many studies, people with hypertension, coronary heart disease, obesity and some other chronic diseases are more likely to have covid-19 diagnosed. This paper aims to analyze the prevention, treatment and management strategies of covid-19 for patients with hypertension, diabetes, obesity, cardiovascular disease, and Chronic obstructive pulmonary disease (COPD). Dispensing regimens during pandemic are discussed as well to minimize exposure and avoid contamination of the population.

Publisher

Darcy & Roy Press Co. Ltd.

Reference17 articles.

1. WHO Coronavirus (COVID-19) Dashboard. Retrieved October 9, 2022, from https://covid19.who.int/.

2. WHO. WHO Director-General's opening remarks at the media briefing on COVID-19. 2022. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020.

3. WHO. Noncommunicable diseases. 2022. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.

4. National Cardiovascular Disease Center. China Cardiovascular Health and Disease Report 2019 [M]. Beijing: Science Press, 2020.

5. Barber M.S., et al. A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review. Complement Ther Med. 2021; 63: 102788.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3